ZNF425
gene geneOn this page
Summary
ZNF425 (zinc finger protein 425, HGNC:20690) is a protein-coding gene on chromosome 7q36.1, encoding Zinc finger protein 425 (Q6IV72). Acts as a transcriptional repressor.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Involved in negative regulation of DNA-templated transcription. Located in cytoplasm and nucleoplasm.
Source: NCBI Gene 155054 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 105 total
- MANE Select transcript:
NM_001001661
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20690 |
| Approved symbol | ZNF425 |
| Name | zinc finger protein 425 |
| Location | 7q36.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000204947 |
| Ensembl biotype | protein_coding |
| OMIM | 619507 |
| Entrez | 155054 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 4 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000378061, ENST00000483014, ENST00000484196, ENST00000495685, ENST00000926832, ENST00000951283
RefSeq mRNA: 1 — MANE Select: NM_001001661
NM_001001661
CCDS: CCDS34773
Canonical transcript exons
ENST00000378061 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001476104 | 149112137 | 149112295 |
| ENSE00001476105 | 149118222 | 149118348 |
| ENSE00001476106 | 149126196 | 149126324 |
| ENSE00001944997 | 149102784 | 149105566 |
Expression profiles
Bgee: expression breadth ubiquitous, 159 present calls, max score 77.81.
FANTOM5 (CAGE): breadth broad, TPM avg 1.0429 / max 15.1707, expressed in 638 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 86728 | 1.0429 | 638 |
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.81 | gold quality |
| secondary oocyte | CL:0000655 | 73.66 | silver quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 73.59 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 73.42 | gold quality |
| ventricular zone | UBERON:0003053 | 73.14 | gold quality |
| ganglionic eminence | UBERON:0004023 | 73.14 | gold quality |
| stromal cell of endometrium | CL:0002255 | 73.04 | gold quality |
| cortical plate | UBERON:0005343 | 72.96 | gold quality |
| prefrontal cortex | UBERON:0000451 | 72.41 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 70.77 | gold quality |
| gastrocnemius | UBERON:0001388 | 70.66 | gold quality |
| muscle of leg | UBERON:0001383 | 70.52 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 70.00 | gold quality |
| right frontal lobe | UBERON:0002810 | 69.75 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 69.08 | gold quality |
| cerebellar cortex | UBERON:0002129 | 69.07 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 68.90 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 68.59 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 68.59 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 68.00 | gold quality |
| muscle tissue | UBERON:0002385 | 67.83 | gold quality |
| cerebellum | UBERON:0002037 | 67.79 | gold quality |
| lower esophagus | UBERON:0013473 | 67.71 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 67.68 | gold quality |
| frontal cortex | UBERON:0001870 | 67.68 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 67.67 | gold quality |
| body of uterus | UBERON:0009853 | 67.59 | gold quality |
| islet of Langerhans | UBERON:0000006 | 67.58 | gold quality |
| neocortex | UBERON:0001950 | 67.51 | gold quality |
| popliteal artery | UBERON:0002250 | 67.48 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.67 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
52 targeting ZNF425, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-6744-5P | 99.93 | 66.82 | 748 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-4302 | 99.89 | 67.94 | 1187 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
| HSA-MIR-202-5P | 99.78 | 67.65 | 991 |
| HSA-MIR-8076 | 99.78 | 68.52 | 1170 |
| HSA-MIR-320A-3P | 99.77 | 69.73 | 2107 |
| HSA-MIR-320B | 99.77 | 69.73 | 2107 |
| HSA-MIR-320C | 99.77 | 69.73 | 2107 |
| HSA-MIR-320D | 99.77 | 69.73 | 2107 |
| HSA-MIR-4429 | 99.77 | 69.62 | 2111 |
| HSA-MIR-7-5P | 99.67 | 70.53 | 1809 |
| HSA-MIR-4261 | 99.59 | 70.30 | 3415 |
| HSA-MIR-4437 | 99.52 | 65.29 | 1266 |
| HSA-MIR-186-3P | 99.51 | 66.24 | 1685 |
| HSA-MIR-147B-5P | 99.45 | 70.62 | 2432 |
| HSA-MIR-4427 | 99.34 | 70.33 | 1854 |
| HSA-MIR-7515 | 99.31 | 68.22 | 1795 |
| HSA-MIR-504-3P | 99.30 | 67.18 | 1745 |
Literature-anchored findings (GeneRIF, showing 1)
- Over-expression of ZNF425 inhibits the transcriptional activities of SRE, AP-1, and SRF. Deletion analysis indicates that the C2H2 domain is the main region responsible for the repression. (PMID:21266108)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300)
Protein
Protein identifiers
Zinc finger protein 425 — Q6IV72 (reviewed: Q6IV72)
All UniProt accessions (3): A0A090N7U3, Q6IV72, C9JNW7
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a transcriptional repressor.
Subcellular location. Nucleus. Cytoplasm.
Domain organisation. The C2H2 domain is necessary for the transcriptional repression.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_001001661* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR003655 | aKRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050589 | Ikaros_C2H2-ZF | Family |
Pfam: PF00096, PF01352
UniProt features (25 total): zinc finger region 19, sequence conflict 3, chain 1, domain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6IV72-F1 | 72.51 | 0.03 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
| R-HSA-9843940 | Regulation of endogenous retroelements by KRAB-ZFP proteins |
MSigDB gene sets: 50 (showing top):
GSE45365_NK_CELL_VS_CD8_TCELL_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CREB3L4_TARGET_GENES, DLX4_TARGET_GENES, ID1_TARGET_GENES, ID2_TARGET_GENES, NAB2_TARGET_GENES, RBM34_TARGET_GENES, SNIP1_TARGET_GENES, TOP2B_TARGET_GENES, ZNF30_TARGET_GENES, ZNF610_TARGET_GENES
GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), negative regulation of DNA-templated transcription (GO:0045892), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (3): nucleus (GO:0005634), nucleoplasm (GO:0005654), cytoplasm (GO:0005737)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
| Regulation of endogenous retroelements | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| DNA-templated transcription | 2 |
| cellular anatomical structure | 2 |
| transcription by RNA polymerase II | 1 |
| negative regulation of RNA biosynthetic process | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
316 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF425 | C7orf33 | Q8WU49 | 507 |
| ZNF425 | DRC11L | A6NCM1 | 481 |
| ZNF425 | ZNF280B | Q86YH2 | 474 |
| ZNF425 | ANTXR1 | Q9H6X2 | 452 |
| ZNF425 | A0A087WTJ2 | A0A087WTJ2 | 448 |
| ZNF425 | OR8B8 | Q15620 | 448 |
| ZNF425 | TMBIM6 | P55061 | 447 |
| ZNF425 | ZBED10P | Q96FA7 | 446 |
| ZNF425 | WDR86 | Q86TI4 | 420 |
| ZNF425 | LRRC61 | Q9BV99 | 419 |
| ZNF425 | YPEL3 | P61236 | 406 |
| ZNF425 | ACOT13 | Q9NPJ3 | 398 |
| ZNF425 | PCMT1 | P22061 | 397 |
| ZNF425 | UGGT2 | Q9NYU1 | 395 |
| ZNF425 | CEP170 | Q5SW79 | 387 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRTAP10-7 | ZNF425 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF425 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (1): KRTAP10-7 (Two-hybrid)
ESM2 similar proteins: A3KN32, A3KN36, O14709, O43296, O75123, P15622, P16373, P17023, P17031, P17097, P52736, P85977, Q07230, Q12901, Q14929, Q29RZ4, Q4V8A8, Q571J5, Q5CZA5, Q5JNZ3, Q5R7I8, Q5RBX0, Q5RBY9, Q5RCD9, Q5RCX4, Q61751, Q61967, Q6GQR8, Q6IV72, Q6NX45, Q6PK81, Q6ZMS4, Q7TNU6, Q7TSH9, Q7Z398, Q7Z7L9, Q8BI99, Q8BIQ3, Q8BLB0, Q8IZ26
Diamond homologs: A2A761, A6NFI3, A6NK75, A6NM28, A6NP11, A6QPT6, A8MQ14, A8MTY0, A8MUV8, B4DU55, B4DX44, B4DXR9, O60290, O75373, O75437, O95780, P0DPD5, P17014, P17032, P35789, P51523, P52736, P52738, Q02525, Q03923, Q03936, Q05481, Q06730, Q06732, Q14587, Q14593, Q14929, Q15928, Q16587, Q2KI58, Q3B7M4, Q3SXZ3, Q3U133, Q49AA0, Q4R6C2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
105 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 96 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
520 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:149112294:CC:C | acceptor_gain | 1.0000 |
| 7:149112295:CC:C | acceptor_gain | 1.0000 |
| 7:149118216:TCTTA:T | donor_loss | 1.0000 |
| 7:149118217:CTTA:C | donor_loss | 1.0000 |
| 7:149118218:TTACC:T | donor_loss | 1.0000 |
| 7:149118219:TAC:T | donor_loss | 1.0000 |
| 7:149118220:A:AC | donor_gain | 1.0000 |
| 7:149118220:AC:A | donor_gain | 1.0000 |
| 7:149118221:C:CC | donor_gain | 1.0000 |
| 7:149118221:C:G | donor_loss | 1.0000 |
| 7:149118221:CC:C | donor_gain | 1.0000 |
| 7:149118310:C:CT | acceptor_gain | 1.0000 |
| 7:149118310:C:T | acceptor_gain | 1.0000 |
| 7:149118348:CCTG:C | acceptor_loss | 1.0000 |
| 7:149118349:CTG:C | acceptor_loss | 1.0000 |
| 7:149112130:TAC:T | donor_loss | 0.9900 |
| 7:149112131:A:AC | donor_gain | 0.9900 |
| 7:149112131:AC:A | donor_loss | 0.9900 |
| 7:149112132:C:CC | donor_gain | 0.9900 |
| 7:149112133:TCACC:T | donor_loss | 0.9900 |
| 7:149112134:CA:C | donor_loss | 0.9900 |
| 7:149112135:A:AC | donor_gain | 0.9900 |
| 7:149112135:A:T | donor_loss | 0.9900 |
| 7:149112136:C:CC | donor_gain | 0.9900 |
| 7:149112136:C:CT | donor_loss | 0.9900 |
| 7:149112153:T:A | donor_gain | 0.9900 |
| 7:149112292:TACC:T | acceptor_gain | 0.9900 |
| 7:149118215:ATCTT:A | donor_loss | 0.9900 |
| 7:149118216:T:C | donor_gain | 0.9900 |
| 7:149118220:ACC:A | donor_gain | 0.9900 |
AlphaMissense
5025 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:149103913:A:G | L653P | 0.997 |
| 7:149103930:G:C | F647L | 0.997 |
| 7:149103930:G:T | F647L | 0.997 |
| 7:149103932:A:G | F647L | 0.997 |
| 7:149104602:G:C | F423L | 0.997 |
| 7:149104602:G:T | F423L | 0.997 |
| 7:149104604:A:G | F423L | 0.997 |
| 7:149104686:G:C | F395L | 0.997 |
| 7:149104686:G:T | F395L | 0.997 |
| 7:149104688:A:G | F395L | 0.997 |
| 7:149104770:G:C | F367L | 0.997 |
| 7:149104770:G:T | F367L | 0.997 |
| 7:149104772:A:G | F367L | 0.997 |
| 7:149103678:G:C | F731L | 0.996 |
| 7:149103678:G:T | F731L | 0.996 |
| 7:149103680:A:G | F731L | 0.996 |
| 7:149103903:G:C | H656Q | 0.996 |
| 7:149103903:G:T | H656Q | 0.996 |
| 7:149104014:G:C | F619L | 0.996 |
| 7:149104014:G:T | F619L | 0.996 |
| 7:149104016:A:G | F619L | 0.996 |
| 7:149104266:G:C | F535L | 0.996 |
| 7:149104266:G:T | F535L | 0.996 |
| 7:149104268:A:G | F535L | 0.996 |
| 7:149104323:G:C | H516Q | 0.996 |
| 7:149104323:G:T | H516Q | 0.996 |
| 7:149104350:A:C | F507L | 0.996 |
| 7:149104350:A:T | F507L | 0.996 |
| 7:149104352:A:G | F507L | 0.996 |
| 7:149104182:G:C | F563L | 0.995 |
dbSNP variants (sampled 300 via entrez): RS1000049038 (7:149125009 A>C), RS1000103298 (7:149122653 G>A), RS1000177579 (7:149109983 T>A,C), RS1000398837 (7:149125310 G>A), RS1001074488 (7:149106740 G>A), RS1001141235 (7:149112580 T>A), RS1001201127 (7:149104968 C>G,T), RS1001242820 (7:149108206 C>T), RS1001413335 (7:149102627 C>G,T), RS1001419438 (7:149110956 G>A), RS1001546049 (7:149117387 G>A), RS1001590807 (7:149108483 C>T), RS1001830286 (7:149123663 T>C), RS1001935328 (7:149116313 G>A), RS1002176463 (7:149123328 A>G,T)
Disease associations
OMIM: gene MIM:619507 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| afuresertib | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| zinc chromate | increases abundance, increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| chromium hexavalent ion | increases abundance, increases expression | 1 |
| nutlin 3 | affects cotreatment, increases expression | 1 |
| ICG 001 | increases expression | 1 |
| abrine | increases expression | 1 |
| NSC668394 | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Ethanol | increases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Camptothecin | increases expression | 1 |
| Dactinomycin | affects cotreatment, increases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Asbestos, Crocidolite | decreases expression | 1 |
| Palmitic Acid | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.